Retracted on Jul 24, 2023. Do not cite it as support.
Source: Retraction Watch, via Crossref · checked Nov 1, 2026 · Read the notice
Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7
Haiyang Zhang, Ting Deng, Shaohua Ge and 11 more
Oncogene · 2018 · CC BY
Abstract
Hepatocellular carcinoma (HCC), the major form of liver cancer, has shown increasing incidence and poor prognosis. Adipose tissue is known to function in energy storage and metabolism regulation by the secretion of adipokines. Circular RNAs (circRNAs), a novel type of noncoding RNA, have recently been recognized as key factors in tumor development, but the role of exosome circRNAs derived from adipose tissues has not been defined yet. Here, adipose-secreted circRNAs were found to regulate deubiquitination in HCC, thus facilitating cell growth. It was observed that exosome circ-deubiquitination (circ-DB) is upregulated in HCC patients with higher body fat ratios. Moreover, in vitro and in vivo studies showed that exo-circ-DB promotes HCC growth and reduces DNA damage via the suppression of miR-34a and the activation of deubiquitination-related USP7. Finally, the results showed that the effects of adipose exosomes on HCC cells can be reversed by knockdown of circ-DB. These results indicate that exosome circRNAs secreted from adipocytes promote tumor growth and reduce DNA damage by suppressing miR-34a and activating the USP7/Cyclin A2 signaling pathway.
Full text
We don’t show the text of a retracted or withdrawn paper. The record stays, so citations to it can be checked.
Cited by papers we hold 21
- Exosomal circRNA: emerging insights into cancer progression and clinical application potential · 2023No notice
- The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies · 2022Not checked
- The emerging roles and mechanisms of exosomal non-coding RNAs in the mutual regulation between adipose tissue and other related tissues in obesity and metabolic diseases · 2022Not checked
- Cancer cell-derived exosomal circUSP7 induces CD8+ T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC · 2021No notice
- Emerging roles of exosomal miRNAs in diabetes mellitus · 2021No notice
- Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies · 2021No notice
- Roles of circRNAs in the tumour microenvironment · 2020No notice
- CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer · 2020No notice
- Tumor‐Derived Exosomes in Immunosuppression and Immunotherapy · 2020No notice
- The significance of exosomes in the development and treatment of hepatocellular carcinoma · 2020No notice
- Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology · 2020No notice
- CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1 · 2020No notice
- Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer · 2020No notice
- The potential of using blood circular RNA as liquid biopsy biomarker for human diseases · 2020No notice
- Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma · 2020No notice
- Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells · 2020No notice
- Identification of Serum Exosomal hsa-circ-0004771 as a Novel Diagnostic Biomarker of Colorectal Cancer · 2019No notice
- Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway · 2019No notice
- Exosomal circRNAs: biogenesis, effect and application in human diseases · 2019No notice
- Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer · 2019No notice
and 1 more
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.